I. Ak Et Al. , "Does the orbital 111In-Octreotide uptake demonstrate the active disease in patients with Grave's Ophtalmopathy: Its relation with clinical activity score," EUROPEAN JOURNAL OF NUCLEAR MEDICINE , vol.28, no.8, pp.1180, 2001
Ak, I. Et Al. 2001. Does the orbital 111In-Octreotide uptake demonstrate the active disease in patients with Grave's Ophtalmopathy: Its relation with clinical activity score. EUROPEAN JOURNAL OF NUCLEAR MEDICINE , vol.28, no.8 , 1180.
Ak, I., Un, N., Zor, E., Vardarel, E., & Yildirim, N., (2001). Does the orbital 111In-Octreotide uptake demonstrate the active disease in patients with Grave's Ophtalmopathy: Its relation with clinical activity score. EUROPEAN JOURNAL OF NUCLEAR MEDICINE , vol.28, no.8, 1180.
Ak, I Et Al. "Does the orbital 111In-Octreotide uptake demonstrate the active disease in patients with Grave's Ophtalmopathy: Its relation with clinical activity score," EUROPEAN JOURNAL OF NUCLEAR MEDICINE , vol.28, no.8, 1180, 2001
Ak, I Et Al. "Does the orbital 111In-Octreotide uptake demonstrate the active disease in patients with Grave's Ophtalmopathy: Its relation with clinical activity score." EUROPEAN JOURNAL OF NUCLEAR MEDICINE , vol.28, no.8, pp.1180, 2001
Ak, I. Et Al. (2001) . "Does the orbital 111In-Octreotide uptake demonstrate the active disease in patients with Grave's Ophtalmopathy: Its relation with clinical activity score." EUROPEAN JOURNAL OF NUCLEAR MEDICINE , vol.28, no.8, p.1180.
@article{article, author={I Ak Et Al. }, title={Does the orbital 111In-Octreotide uptake demonstrate the active disease in patients with Grave's Ophtalmopathy: Its relation with clinical activity score}, journal={EUROPEAN JOURNAL OF NUCLEAR MEDICINE}, year=2001, pages={1180} }